http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
자동 복막투석 환자에서 Leclercia adecarboxylata로 인한 복막염 1예
이헌남 ( Heon Nam Lee ),박진웅 ( Jin Woong Park ),김형수 ( Hyung Soo Kim ),박순호 ( Soon Ho Park ),장제현 ( Jae Hyun Chang ),정우경 ( Woo Kyung Chung ),이현희 ( Hyun Hee Lee ),서일혜 ( Yiel Hae Seo ),김세중 ( Se Joong Kim ) 대한신장학회 2009 Kidney Research and Clinical Practice Vol.28 No.6
Peritonitis in patients undergoing peritoneal dialysis is a major complication and the leading cause of peritoneal dialysis failure. Leclercia adecarboxylata is a motile, gram-negative, facultative anaerobic bacillus of the Enterobacteriaceae family. These bacteria are uncommon pathogen, and rarely isolated from environmental and clinical specimens. Some cases have been reported about peritonitis due to Leclercia adecarboxylata in a patient receiving continuous ambulatory peritoneal dialysis (CAPD). However, there has never been any report about peritonitis in a patient receiving automated peritoneal dialysis (APD). We have isolated Leclercia adecarboxylata from peritoneal fluid in a patient receiving APD, and the patient completely recovered with 14-day treatment of intraperitoneal antibiotics without catheter removal.
이헌남 ( Heon Nam Lee ),정준원 ( Jun Won Chung ),김윤재 ( Yoon Jae Kim ),김의주 ( Eui Joo Kim ),박성근 ( Sung Keun Park ),오경용 ( Kyong Yong Oh ),이영준 ( Young Jun Lee ) 대한내과학회 2012 대한내과학회지 Vol.82 No.5
Cameron ulcers are gastric ulcers or erosions located at mucosal folds in patients with large hiatal hernias. Mechanical trauma, gastric acid injury, or ischemia can cause their formation. Cameron ulcers are frequently seen as incidental findings during upper gastrointestinal endoscopy. About half of patients with these lesions are asymptomatic. However, Cameron ulcers are related to iron deficiency anemia and gastrointestinal bleeding in some cases. Here, we report a case of Cameron ulcers presenting with melena, which was successfully treated with proton pump inhibitors and iron supplementation. (Korean J Med 2012;82:585-588)
유전자 6형 만성C형간염 환자의 유병률과 위험인자 그리고 임상적 특징: 단일기관 경험
신승각 ( Seung Kak Shin ),박수용 ( Soo Yong Park ),정영걸 ( Young Kul Jung ),김의주 ( Eui Joo Kim ),이헌남 ( Heon Nam Lee ),이종준 ( Jong Joon Lee ),권오상 ( Oh Sang Kwon ),최덕주 ( Duck Joo Choi ),김연수 ( Yun Soo Kim ),김주현 ( 대한소화기학회 2015 대한소화기학회지 Vol.65 No.2
Background/Aims: Hepatitis C genotypes 1 and 2 are widely distributed globally. In contrast, genotype 6 is found mainly in Southeast Asia, while genotype 6 is rare in Korea. This study aims to investigate the prevalence, risk factors and clinical characteristics of patients with genotype 6 chronic hepatitis C. Methods: We retrospectively identified 133 HCV-infected patients who underwent HCV genotype analysis between January 2012 and December 2012, and analyzed the prevalence, risk factors and clinical characteristics of patients diagnosed with genotype 6 chronic hepatitis C. Results: Among 133 patients, 53 patients (39.8%) were infected with genotype 1, 62 patients (46.6%) with genotype 2, 2 patients (1.5%) with genotype 3, 14 patients (10.5%) with genotype 6, and 2 patients (1.5%) with mixed genotypes (genotype 1 and 6). The risk factors associated with genotype 6 were acupuncture (n=4, 28.6%), intravenous drug use (n=3, 21.4%), tattoo (n=2, 14.3%), and transfusion (n=2, 14.3%). Of the 14 patients with genotype 6, 6 patients were treated with pegylated interferon and ribavirin. Five patients had reached the end of treatment. All patients reaching end of treatment for genotype 6 showed early virological response and sustained virological response. Conclusions: The prevalence of genotype 6 is 10.5% and mixed infections of genotype 1 and 6 are 1.5% in patients with chronic hepatitis C. A major potential risk factor is intravenous drug use and the treatment response rate to pegylated interferon plus ribavirin is high in patients with genotype 6 chronic hepatitis C. Large scale multicenter studies are needed.